Original Research
This study assesses the impact of cystinosis and treatmentassociated challenges on therapeutic adherence to detect potential leverages of change and propose lines of actions based on patient-reported experience measures.
Review
This article reviews medication nonadherence
in chronic health conditions with particular reference to
treatment-resistant hypertension.
Original Research
Risk evaluation and mitigation strategies (REMS), as mandated by the FDA for medications with the potential for harm, are increasingly incorporating rigid protocols for patient evaluation, but little is known about compliance with these programs. This study assessed adherence to liver function test (LFT) requirements included in the REMS program for bosentan and the results suggest that the program may not have adequately guaranteed adherence to monthly monitoring of LFTs.
